NEW YORK ( TheStreet) -- ADVENTRX Pharmaceuticals (AMEX: ANX) hit a new 52-week low Wednesday as it is currently trading at $1.04, below its previous 52-week low of $1.73 with 1.5 million shares traded as of 9:38 a.m. ET. Average volume has been 1.1 million shares over the past 30 days. ADVENTRX has a market cap of $55.3 million and is part of the health care sector and drugs industry. Shares are down 19.9% year to date as of the close of trading on Tuesday. ADVENTRX Pharmaceuticals, Inc., specialty pharmaceutical company, focuses on acquiring, developing, and commercializing proprietary product candidates. Its lead products include Exelbine or ANX-530, an emulsion formulation of the chemotherapy drug vinorelbine.
Practice your ANX trading strategies and win cash in our stock game.
Shares of ADVENTRX Pharmaceuticals (AMEX:ANX) were gapping down Friday morning with an open price 21.5% lower than Thursday's closing price. The stock closed at 93 cents yesterday and opened today's trading at 73 cents.